336 related articles for article (PubMed ID: 19856044)
1. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
2. Endometriosis-associated ovarian cancer: a clinicopathologic review.
Steed H; Chapman W; Laframboise S
J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
[TBL] [Abstract][Full Text] [Related]
3. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
4. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
5. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
9. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
10. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
11. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
14. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
15. ARID1A mutations in endometriosis-associated ovarian carcinomas.
Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
[TBL] [Abstract][Full Text] [Related]
17. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of endometriosis and its clinical significance.
Nezhat F; Apostol R; Mahmoud M; el Daouk M
Fertil Steril; 2014 Aug; 102(2):342-4. PubMed ID: 24880652
[No Abstract] [Full Text] [Related]
19. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
Okuda T; Otsuka J; Sekizawa A; Saito H; Makino R; Kushima M; Farina A; Kuwano Y; Okai T
Gynecol Oncol; 2003 Mar; 88(3):318-25. PubMed ID: 12648581
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
